首页> 外文期刊>Journal of Pain Research >Pre-emptive scalp infiltration with dexamethasone plus ropivacaine for postoperative pain after craniotomy: a protocol for a prospective, randomized controlled trial
【24h】

Pre-emptive scalp infiltration with dexamethasone plus ropivacaine for postoperative pain after craniotomy: a protocol for a prospective, randomized controlled trial

机译:地塞米松加罗哌卡因在先发性头皮浸润开颅手术后的术后疼痛:一项前瞻性,随机对照试验的方案

获取原文
           

摘要

Background: Approximately 55–87% of the patients undergoing craniotomy experience moderate to severe pain during the first 48 hrs after surgery, which negatively influences patients’ postoperative rehabilitation. Recently, local infiltration of analgesia (LIA) has been widely performed clinically as a promising analgesic method that could avoid the side effects of analgesics but only has a short pain-free duration; researchers have clarified that the addition of dexamethasone to LIA could provide significant analgesic effects and significantly prolong the duration of analgesic effects without obvious complications for various types of surgeries. To date, no studies have evaluated the addition of dexamethasone to LIA for patients receiving craniotomy. The aim of the study was to test the hypothesis that pre-emptive scalp infiltration with a steroid (dexamethasone) plus a local anesthetic (ropivacaine) could achieve superior postoperative analgesic effects to a local anesthetic (ropivacaine) alone in adult patients undergoing a craniotomy. Study design and methods: This study is a randomized controlled trial that will include one intervention and one control group involving a total of 140 adults scheduled for elective craniotomy for resection of supratentorial tumors under general anesthesia and with an anticipated full recovery within 2 hrs postoperatively. The intervention will involve pre-emptive scalp infiltration with ropivacaine plus dexamethasone (the dexamethasone group) or ropivacaine alone (the control group), and the participants in both groups will complete a 6-month follow-up. The primary outcome will be the cumulative sufentanil consumption within 48 hrs postoperatively. Discussion: The intervention, if effective, this study will provide clinically important information on the role of dexamethasone in scalp infiltration for post-craniotomy pain management.
机译:背景:开颅手术的患者中约有55–87%在手术后的前48小时内经历了中度至重度疼痛,这对患者的术后康复产生了负面影响。最近,作为一种有希望的镇痛方法,临床上已广泛进行局部镇痛(LIA)治疗,该方法可避免镇痛药的副作用,但持续时间短。研究人员已经阐明,向LIA添加地塞米松可以提供显着的镇痛作用,并显着延长镇痛作用的持续时间,而不会为各种类型的手术带来明显的并发症。迄今为止,尚无研究评估接受开颅手术的患者向LIA添加地塞米松。该研究的目的是检验以下假设:在接受开颅手术的成年患者中,使用类固醇(地塞米松)加局麻药(罗哌卡因)先发性头皮浸润可达到优于局麻药(罗哌卡因)的更好的术后镇痛效果。研究设计和方法:这项研究是一项随机对照试验,将包括一个干预措施和一个对照组,涉及总共140名计划在全麻下行开颅手术切除脑幕肿瘤的成年人,预计术后2小时内可完全康复。该干预将涉及使用罗哌卡因加地塞米松(地塞米松组)或单独使用罗哌卡因(对照组)的先发性头皮浸润,两组参与者均将完成6个月的随访。主要结局是术后48小时内累计舒芬太尼的消耗量。讨论:该干预措施(如果有效)将为地塞米松在颅骨切开术后疼痛管理中提供有关地塞米松在头皮浸润中作用的临床重要信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号